NCT00470327Recruiting
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Source: ClinicalTrials.gov · Last updated 9 Jun 2026
Brief summary (registry, in English)
We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group for comparator purposes. In doing so, we will be able to describe the "phenotypic" expression of these diseases.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 4000 (estimated)
- First submitted
- 3 May 2007
- Start date
- Sept 2005
- Primary completion date
- Dec 2030
- Lead sponsor
- University of Chicago
- Diseases
- Idiopathic pulmonary fibrosis
- NCT number
- NCT00470327
What you commit to
- Study type: Observational
- Planned participants: 4000
- From Sept 2005 to the primary completion date, Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Does not have Interstitial lung disease
Who the study is looking for
- Interstitial lung disease
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Chicago Coordinator of this site? Confirm its status | Chicago | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.